false
0000771999
0000771999
2026-06-23
2026-06-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): June 23, 2026
DSS,
INC.
(Exact
name of registrant as specified in its charter)
| New
York |
|
001-32146 |
|
16-1229730 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
275
Wiregrass Pkwy,
West
Henrietta, NY |
|
14586 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (585) 325-3610
N/A
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Ticker
symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, $0.02 par value per share |
|
DSS |
|
The
NYSE American LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933
or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01 Entry into a Material Definitive Agreement.
Securities
Purchase Agreement with Alset, Inc.
On
June 23, 2026, DSS, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with
Alset, Inc. (“Alset”), a Texas corporation, pursuant to which Alset will loan the Company $1,000,000, in exchange for a convertible
promissory note (the “Note”) and warrants to purchase 17,777,776 shares of the Company’s common stock pursuant to a
warrant agreement (the “Warrant Agreement”).
The
Note, SPA and Warrant Agreement are collectively referred to herein as the “Transaction Documents”.
The
closing of the transactions contemplated by the Transaction Documents is subject to certain closing conditions, including approval of
the Company’s stockholders.
The
Note will bear a simple interest at a rate of 3% per annum. Pursuant to the terms of the Note, Alset may convert any outstanding principal
and accrued interest into shares of the Company’s common stock at a conversion price of $0.45 per share at any time prior to the
maturity date, which is five (5) years from the date of issuance.
The
Warrant Agreement entitles Alset to purchase up to 17,777,776 shares of the Company’s common stock at an exercise price of $0.50
per share. The warrants expire on their third anniversary.
Related
Party Transaction
The
Company and Alset are related parties under common control of Chan Heng Fai, who serves as Chairman of the Company and is also Chairman
and Chief Executive Officer of Alset. Chan Tung Moe, a director and Co-Chief Executive Officer of Alset, is also a director of the Company.
Lim Sheng Hon Danny, a director and officer of Alset, is also a director of the Company. Certain independent directors of Alset also
serve as directors of the Company.
The
Transaction Documents were approved by the Company’s Board of Directors and, where applicable, its Audit Committee. Any interested
directors recused themselves from deliberations and voting regarding the Transaction Documents.
The
foregoing summary does not purport to be complete and is qualified in its entirety by reference to the Transaction Documents, copies
of which are filed as Exhibits 10.1, 10.2 and 10.3 hereto and incorporated herein by reference.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits:
| Number |
|
Description |
| 10.1 |
|
Form
of Common Stock Purchase Warrant issued to Alset, Inc., dated as of June 23, 2026 |
| 10.2 |
|
Securities
Purchase Agreement, between DSS, Inc. and Alset, Inc., dated as of June 23, 2026 |
| 10.3 |
|
Convertible
Promissory Note issued by DSS, Inc., dated as of June 23, 2026 |
| 104 |
|
Cover
page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K
to be signed on its behalf by the undersigned hereunto duly authorized.
| |
DSS,
INC. |
| |
|
|
| Date:
June 25, 2026 |
By: |
/s/
Jason Grady |
| |
Name: |
Jason
Grady |
| |
Title: |
Interim
Chief Executive Officer |